torcetrapib has been researched along with oleanolic acid 3-acetate in 1 studies
| Studies (torcetrapib) | Trials (torcetrapib) | Recent Studies (post-2010) (torcetrapib) | Studies (oleanolic acid 3-acetate) | Trials (oleanolic acid 3-acetate) | Recent Studies (post-2010) (oleanolic acid 3-acetate) |
|---|---|---|---|---|---|
| 273 | 28 | 83 | 36 | 0 | 24 |
| Protein | Taxonomy | torcetrapib (IC50) | oleanolic acid 3-acetate (IC50) |
|---|---|---|---|
| Protease | Human immunodeficiency virus 1 | 3.4 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, G; Chang, Y; Chen, D; He, X; Huang, X; Liu, J; Luo, H; Ni, S; Shen, Q; Sun, H; Wang, P; Wen, X; Zhou, H | 1 |
1 other study(ies) available for torcetrapib and oleanolic acid 3-acetate
| Article | Year |
|---|---|
Discovery of pentacyclic triterpene 3β-ester derivatives as a new class of cholesterol ester transfer protein inhibitors.
Topics: Animals; Cholesterol Ester Transfer Proteins; Dose-Response Relationship, Drug; Drug Discovery; Esters; Guinea Pigs; Humans; Mice; Mice, Transgenic; Molecular Structure; Structure-Activity Relationship; Triterpenes | 2017 |